Modeling Transcriptional Rewiring in Neutrophils Through the Course of Treated Juvenile Idiopathic Arthritis

Zihua Hu1,2,3, Kaiyu Jiang4, Mark Barton Frank5

  • 1Center for Computational Research, New York State Center of Excellence in Bioinformatics & Life Sciences, State University of New York at Buffalo, Buffalo, NY, 14260, USA. zihuahu@ccr.buffalo.edu.

Scientific Reports
|May 19, 2018
PubMed

Insights

Juvenile idiopathic arthritis (JIA) neutrophils show altered gene expression. Therapy significantly reshapes these networks, with inactive disease resembling healthy controls more closely.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Neutrophils in polyarticular juvenile idiopathic arthritis (JIA) exhibit abnormal transcriptional patterns linked to metabolic issues.
  • Understanding therapy's impact on gene expression in JIA is crucial.

Purpose of the Study:

  • To investigate the effects of therapy on mRNA and miRNA expression networks in polyarticular JIA.
  • To compare transcriptional profiles across untreated active JIA, treated active JIA, and inactive JIA states.

Main Methods:

  • Utilized exon and miRNA microarrays to analyze gene expression in children with JIA and healthy controls.
  • Compared gene expression profiles in untreated active JIA (ADU), treated active JIA (ADT), and inactive disease (ID) groups against healthy controls (HC).

Main Results:

  • Therapy induced significant re-ordering of mRNA and miRNA expression networks.
  • Each disease state (ADU, ADT, ID) had a distinct transcriptional profile, with ADT differing most from HC.
  • Inactive disease (ID) profiles more closely resembled healthy controls (HC) than active disease states.
  • mRNA and miRNA expression changes were mirrored, indicating coordinated regulation.
  • Therapeutic response is complex, not a simple linear gene correction process.

Conclusions:

  • Therapy substantially alters gene expression networks in polyarticular JIA.
  • Combinatorial regulation by miRNA and transcription factors (TFs) may drive dynamic transcriptome changes during treatment.
  • Distinct transcriptional states exist for untreated active, treated active, and inactive JIA.

Related Concept Videos

Transcription01:10

Transcription

Overview
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
157.1K
Transcription01:17

Transcription

Transcription is the synthesis of RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in correctly synthesizing messenger RNA (mRNA). Transcriptional regulation is responsible for the differentiation of different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds of RNA Molecules
In eukaryotes,...
33.4K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.9K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.9K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K